Moderna, Inc.
MRNA
$175.93
-$6.42-3.52%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
12/6/2022
-
Zacks Investment Research
12/5/2022
-
Ars Technica
12/5/2022
-
Stock Options Channel
12/5/2022
-
MarketWatch.com - GOOG
12/5/2022
-
Benzinga
12/5/2022
-
MarketWatch.com
12/5/2022
-
Zolmax
12/4/2022
-
The Motley Fool UK
12/3/2022
-
Ticker Report
12/3/2022
-
Zolmax
12/3/2022
-
Zolmax
12/3/2022
-
Ticker Report
12/3/2022
-
Zolmax
12/3/2022
-
The Motley Fool UK
12/2/2022
-
Zolmax
12/2/2022
-
Simply Wall St
12/2/2022
-
Ticker Report
12/2/2022
-
Ticker Report
12/1/2022
-
Insider
12/1/2022
-
Ticker Report
12/1/2022
-
Zolmax
12/1/2022
-
Fool.com Headlines
12/1/2022
-
Zolmax
12/1/2022
-
The Motley Fool UK
11/30/2022
-
Taipei Times
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 3, 2022
Period Date
Friday, September 30, 2022
Next Filing
Week of Feb 20 and 24 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 714 6500
Address
200 Technology Square
Cambridge, MA 02139
Cambridge, MA 02139
Country
Year Founded
Business Description
Sector
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases...
more
